š”š²šš š¦ššŗšŗš®šæš
ā¢ Sun Pharma's Q2 results have impressed brokerages, with some raising their target prices for the stock.
ā¢ The drugmaker reported a 5% increase in net profit and an 11.3% increase in revenue, beating Street estimates.
ā¢ The growth was driven by strong global specialty sales and a strong performance in the domestic market, despite a decline in US sales.